Evaluating Immune Cell Therapy Potency

Adoptive cell therapies offer a promising approach for the treatment of numerous diseases including cancer, autoimmune and infectious diseases. In particular, autologous CAR T cell therapy provides an unparalleled adaptive response to hematological tumors – minimizing the risk of systemic side effects and bio-incompatibility.

Researchers and manufacturers must ensure reproducibility, efficacy and potency before treatments reach the clinic. Hence, efficient tools to monitor potency ex-vivo are essential to ensure safe and consistent cell therapy products.

Download this eBook to learn about:

• The current state of CAR T therapies
• Tools to evaluate the potency of novel cell therapies in vitro
• Strategic collaborations to transform manufacturing of cell therapies